552331-43-8 Usage
Uses
Used in Pharmaceutical Development:
7-Chloro-pyrido[2,3-d]pyrimidin-4-ol is utilized as a key intermediate in the synthesis of pharmaceutical compounds for various therapeutic areas. Its unique structural features allow it to modulate biological activities, making it a valuable component in the development of novel drugs.
Used in Research and Development:
As a research tool, 7-chloro-pyrido[2,3-d]pyrimidin-4-ol aids scientists in understanding the interactions between small molecules and biological macromolecules or enzymes. This knowledge is crucial for the advancement of drug discovery and the study of molecular mechanisms in biological systems.
Used in Chemical Synthesis:
In the chemical synthesis industry, 7-chloro-pyrido[2,3-d]pyrimidin-4-ol serves as a building block for the creation of more complex molecules with specific properties. Its reactivity and structural attributes make it a versatile component in the synthesis of various chemical entities.
Used in Drug Discovery:
7-Chloro-pyrido[2,3-d]pyrimidin-4-ol is employed as a lead compound in drug discovery processes. Its potential to interact with biological targets makes it a promising candidate for further optimization and development into effective therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 552331-43-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,5,2,3,3 and 1 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 552331-43:
(8*5)+(7*5)+(6*2)+(5*3)+(4*3)+(3*1)+(2*4)+(1*3)=128
128 % 10 = 8
So 552331-43-8 is a valid CAS Registry Number.
552331-43-8Relevant articles and documents
Kinase inhibitors
-
, (2008/06/13)
Compounds having the formula are useful for inhibiting protein kinases. Also disclosed are compositions which inhibit protein kinases and methods of inhibiting protein kinases in a patient.
Kinase inhibitors
-
Page/Page column 46, (2010/01/31)
Compounds having the formula are useful for inhibiting protein kinases. Also disclosed are compositions which inhibit protein kinases and methods of inhibiting protein kinases in a patient.